Ivaltinostat is a potent histone deacetylase (HDAC) inhibitor classified as an epigenetic modulator, primarily used in the treatment of solid tumors and hematological malignancies by inducing cell cycle… Read more
Ivaltinostat is a potent histone deacetylase (HDAC) inhibitor classified as an epigenetic modulator, primarily used in the treatment of solid tumors and hematological malignancies by inducing cell cycle arrest and apoptosis. Pharmaceutical laboratories utilize high-quality reference standards of Ivaltinostat and its related compounds to ensure accuracy in analytical testing, method validation, and quality control. Researchers rely on Ivaltinostat-d7, a stable isotope labelled compound, as an internal standard for precise quantitative analysis in bioanalytical studies, particularly when performing impurity profiling or monitoring drug degradation. By incorporating these specialized compounds into analytical workflows, laboratories can rigorously characterize the parent drug and its metabolites throughout the drug development lifecycle, supporting compliance with regulatory requirements for safety and efficacy in pharmaceutical research.